A review of the therapeutic properties of dithiocarbamates

A review of the therapeutic properties of... | F1000Research "use strict";function _typeof(t){return(_typeof="function"==typeof Symbol&&"symbol"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&"function"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?"symbol":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement("iframe");r.style.cssText="display:none",r.name="__tcfapiLocator",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&"boolean"==typeof n[3]&&(e=n[3],"function"==typeof n[2]&&n[2]("set",!0)):"ping"===n[0]?"function"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:"stub"}):o.push(n)},n.addEventListener("message",(function(t){var e="string"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n="object"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,"*")}),n.parameter)}),!1))};"undefined"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://f1000research.com/articles/11-243" }, "headline": "A review of the therapeutic properties of dithiocarbamates", "datePublished": "2022-02-28T12:01:53", "dateModified": "2022-02-28T12:01:53", "author": [ { "@type": "Person", "name": "Toluwani Tella" }, { "@type": "Person", "name": "Carolina H. Pohl" }, { "@type": "Person", "name": "Ayansina Ayangbenro" } ], "publisher": { "@type": "Organization", "name": "F1000Research", "logo": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 480, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 1200, "width": 150 }, "description": "The persistence of infectious diseases that continue to plague the world, as well as the formation of harmful substances within the human body, such as free radicals and reactive oxygen species (ROS) have sparked new research. Thus, the need for innovative approaches for developing new or modification of existing therapeutic agents. The design of biologically important metal complexes of dithiocarbamates (DTCs) has been made possible by recent advancements in innovative research. Dithiocarbamates are reduced thiuram disulfides with excellent complexing capabilities and have various applications. They are potent and work in tandem with the core metal ions of coordinating compounds to produce synergistic effects. Dithiocarbamates have many uses, including as antidotes for metal poisoning, cisplatin or carboplatin toxicity, and clinical trials for cancer, Lyme disease, human immunodeficiency virus and antibiotics. They exert anti-oxidant effect in cells. The understanding of the mechanisms of action of this therapeutic agent is important in drug repurposing. This review highlights the protective and therapeutic properties of dithiocarbamate compounds in biological systems." } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://f1000research.com/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://f1000research.com/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://f1000research.com/articles/11-243", "name": "A review of the therapeutic properties of dithiocarbamates" } } ] } Home Browse A review of the therapeutic properties of dithiocarbamates ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article Tella T, Pohl CH and Ayangbenro A. A review of the therapeutic properties of dithiocarbamates [version 1; peer review: 2 approved with reservations] . F1000Research 2022, 11 :243 ( https://doi.org/10.12688/f1000research.109553.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Review A review of the therapeutic properties of dithiocarbamates [version 1; peer review: 2 approved with reservations] Toluwani Tella https://orcid.org/0000-0002-0162-7070 1 , Carolina H. Pohl 2 , Ayansina Ayangbenro https://orcid.org/0000-0002-3220-1873 3 Toluwani Tella https://orcid.org/0000-0002-0162-7070 1 , Carolina H. Pohl 2 , Ayansina Ayangbenro https://orcid.org/0000-0002-3220-1873 3 PUBLISHED 28 Feb 2022 Author details Author details 1 Biochemistry, North-West University, Mmabatho, North West, 2735, South Africa 2 Microbiology and Biochemistry, University of the Free State, Bloemfontein, Free State, 9301, South Africa 3 Food Security and Safety, North-West University, Mmabatho, North West, 2735, South Africa Toluwani Tella Roles: Conceptualization, Data Curation, Investigation, Writing – Original Draft Preparation, Writing – Review & Editing Carolina H. Pohl Roles: Project Administration, Resources, Writing – Review & Editing Ayansina Ayangbenro Roles: Data Curation, Investigation, Resources, Writing – Original Draft Preparation, Writing – Review & Editing OPEN PEER REVIEW DETAILS REVIEWER STATUS Abstract The persistence of infectious diseases that continue to plague the world, as well as the formation of harmful substances within the human body, such as free radicals and reactive oxygen species (ROS) have sparked new research. Thus, the need for innovative approaches for developing new or modification of existing therapeutic agents. The design of biologically important metal complexes of dithiocarbamates (DTCs) has been made possible by recent advancements in innovative research. Dithiocarbamates are reduced thiuram disulfides with excellent complexing capabilities and have various applications. They are potent and work in tandem with the core metal ions of coordinating compounds to produce synergistic effects. Dithiocarbamates have many uses, including as antidotes for metal poisoning, cisplatin or carboplatin toxicity, and clinical trials for cancer, Lyme disease, human immunodeficiency virus and antibiotics. They exert anti-oxidant effect in cells. The understanding of the mechanisms of action of this therapeutic agent is important in drug repurposing. This review highlights the protective and therapeutic properties of dithiocarbamate compounds in biological systems. READ ALL READ LESS Keywords Dithiocarbamate, Biological properties, Antioxidant properties, Apoptosis, Reactive oxygen species Corresponding Author(s) Ayansina Ayangbenro ( [email protected] ) Close Corresponding author: Ayansina Ayangbenro Competing interests: No competing interests were disclosed. Grant information: The author(s) declared that no grants were involved in supporting this work. Copyright: © 2022 Tella T et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: Tella T, Pohl CH and Ayangbenro A. A review of the therapeutic properties of dithiocarbamates [version 1; peer review: 2 approved with reservations] . F1000Research 2022, 11 :243 ( https://doi.org/10.12688/f1000research.109553.1 ) First published: 28 Feb 2022, 11 :243 ( https://doi.org/10.12688/f1000research.109553.1 ) Latest published: 28 Feb 2022, 11 :243 ( https://doi.org/10.12688/f1000research.109553.1 ) Introduction Dithiocarbamates (DTCs) have lately reappeared as possible therapeutic agents because of their metal chelating properties and affinity for thiol groups ( Kaul et al. , 2021 ). Only a few studies have shown the growing DTCs’ importance in medicine and the promise for various medicinal applications. DTC moieties have been studied as antimicrobial agents, cancer therapies, and neurology and cardiology applications. New chemical compounds containing DTC moieties have also been developed and investigated for anti-cancer, neurological, and antimicrobial uses ( Kaul et al. , 2021 ). Dithiocarbamates are biologically active chemical compounds with the -N(C=S)S- moiety that is made by reacting amines or their corresponding derivatives with carbon disulfide in the presence of a base. They are a type of soft sulfur donor ligand (mono-anionic 1,1-dithiolate), capable of forming stable metal complexes ( Adeyemi & Onwudiwe, 2020 ). These ligands are mono-anionic 1,1-dithiolate. DTC ligands have a significant metal binding potential because of the presence of two sulfur atoms in their structure that are available for complexation, which are effective in enzyme inhibition in biological systems ( Adeyemi & Onwudiwe, 2020 ; Yeo et al. , 2021 ). DTC ligands are lipophilic and can act as mono- or bi-dentate bridging ligands for metal ions ( Hogarth, 2005 ). Their widespread use and applications are due to the relative simplicity of H + replacement from the -SH group inside their molecules, as well as the potential for complex formation. DTCs can suppress bacterial growth in biological systems by modifying the metabolic processes of the organism. The existence of carbon–sulfur bonds has been attributed to most biological features exhibited by dithiocarbamate molecules. This helps with the synthesis of organic intermediates with interesting chemistry ( Movassagh & Shokri, 2012 ). In research, their strong nucleophilic attributes and unique characteristics to perform a redox reaction have been credited with their application in enzyme catalysis, redox signaling and protein folding ( Lal, 2014 ). They also demonstrate anticancer capabilities and the potential for usage in treating various ailments, including viral infections and inflammation. Key proteins involved in apoptosis, degradation, oxidative stress, and transcription can be altered to help achieve these goals ( Buac et al. , 2012 ). The antioxidant behavior of dithiocarbamate includes scavenging the superoxide radical and eliminating hydrogen peroxide ( Mankhetkorn et al ., 1994 ), peroxynitrite and the hydroxyl radical ( Liu et al ., 1996 ) and peroxyl radical, a product of lipid peroxidation ( Zanocco et al ., 1989 ). Excessive generation of free radicals causes damage to DNA, lipids, and proteins, which promote aging, cancer, and various brain and cardiac problems ( Onwudiwe & Ekennia, 2017 ). Dithiocarbamate thiyl radicals are formed when DTCs react with nitrogen species and reactive oxygen, and then dimerize to form thiuram disulfides ( Zanocco et al ., 1989 ), the oxidized form of DTCs. Thiuram disulfides, which are characterized by their intense oxidation of GSH and protein thiols, are responsible for much of the pro-oxidant effects of DTCs. ( Nobel et al ., 1995 ). The oxidation of diethyldithiocarbamate and PDTC by copper (II) is an example of thiuram disufide production that is metal-dependent ( Burkitt et al ., 1998 ). In studies of DTC activity, the antioxidant properties of these compounds have been emphasized, whereas their pro-oxidant properties have received less attention. Types and structure of dithiocarbamates Dithiocarbamates are divided into four groups: a) Monoalkyldithiocarbamates e.g. ethyldithiocarbamate b) Asymmetric (dialkyldithiocarbamate) e.g. ethylmethyldithiocarbamate c) Symmetric (dialkyldithiocarbamate) e.g. diethyldithiocarbamate d) Heterocyclic dithiocarbamates e.g. pyrrolidinedithiocarbamate Free radicals, reactive oxygen species and oxidative stress Molecules or molecular fragments with one or more unpaired electrons in atomic or molecular orbitals are known as free radicals ( Halliwell & Gutteridge, 2006 ). The free radical usually has a lot of reactivity because of the unpaired electron(s). The most common type of radical species produced in living systems is radicals originating from oxygen ( Miller et al. , 1990 ). The electrical arrangement of molecular oxygen (dioxygen) is unusual, making it a radical. When one electron is added to dioxygen, the superoxide anion radical (O 2 · − ) is generated ( Miller et al. , 1990 ). Superoxide anion is the "primary" ROS, formed either using metabolic processes or after physical irradiation "activates" oxygen. It can then combine with other molecules to generate five "secondary" ROS, either directly or through enzyme or metal-catalyzed processes ( Valko et al. , 2005 ). The most prevalent ROS include superoxide anion, hydrogen peroxide, peroxyl radicals, and highly reactive hydroxyl (OH − ) radicals. Although, oxygen is required by cells, its metabolites such as the ROS are lethal to cells ( de Lamirande & Gagnon, 1995 ). As a result of its toxicity to cells, ROS must continually be inactivated to keep only a small amount necessary to maintain normal cell function. “Oxidative stress” (OS) is a condition associated with an increased rate of cellular damage induced by oxygen and oxygen-derived oxidants ( Sikka et al. , 1995 ). The imbalance between ROS and the antioxidant defense mechanism of the cell also causes oxidative stress ( Sikka, 2001 ). Carcinogenesis, aging, infection, physical injury, acquired immunodeficiency syndrome, and toxin exposure have all been linked to ROS ( Joyce, 1987 ). It's also been hypothesized that oxidative stress plays a role in many disorders linked to reproductive dysfunction ( Sharma & Agarwal, 1996 ). Dithiocarbamates in treatment and prevention of organ damage Pyrrolidine dithiocarbamate (PDTC) is an antioxidant and an inhibitor of NF-κB. In cells treated with IL-1, LPS, phorbol ester, and TNF-α, micromolar levels of PDTC inhibited the release of the inhibitory subunit IκB from the latent cytoplasmic form of NF-κB ( Schreck et al. , 1992 ). Hepatic fibrosis, triggered by hepatocyte damage results in the recruitment of inflammatory cells and the subsequent release of cytokines and growth factors ( Muriel, 2007a ; Muriel, 2007b ) that are thought to link the inflammatory and reparative phases of fibrosis by activating hepatic stellate cells (HSC) ( Parsons et al. , 2007 ). HSC is triggered by oxidative stress and responds to IL-1β and TNF-α therapy, resulting in NF-κB nuclear translocation and I-κBα breakdown. Activated HSCs are the primary source of extracellular matrix synthesis, and the expression of adhesion molecules and cytokines contributes to liver injury ( Hellerbrand et al. , 1998 ). In experimental models of liver damage, activation of NF-κB has been linked to the pathophysiology of cell injury. In a rat model of thioacetamide-induced liver failure, Bruck et al. (2002) investigated whether PDTC could reduce hepatic damage. They discovered that giving thioacetamide-treated animals PDTC intraperitoneally reduced immediate liver damage and increased survival. Reduced oxidative stress, reduced hepatic hydroxyproline levels, inhibition of NF-κB, reduced spleen weight and fibrosis score, as well as inhibition of HSC activation, reduced collagen content, and tissue inhibitor of metalloproteinase-2 and collagen α1(I) gene expression in the liver of PDTC-treated rats, could all contribute to this effect. Eren et al . (2010) reported that PDTC reduced biochemical and structural derangement of diabetic lungs. Another finding revealed that in the rat aorta, pyrrolidine dithiocarbamate inhibits the loss of contractile responsiveness caused by interleukin-1-mediated stimulation of inducible nitric oxide synthase ( Schini-Kerth et al. , 1994 ). Borghi et al . (2018) reported that in the kidney, PDTC inhibited diclofenac-induced morphological changes, oxidative stress, NF-κB activation, pro-inflammatory cytokine production and increased antioxidant defenses and anti-inflammatory cytokine (IL-10). Additionally, N-benzyl-D-glucamine dithiocarbamate (BGD) protects against renal toxicity in rats during repeated cisdiamminedichloroplatinum administrations ( Hidaka et al. , 1995 ). Dithiocarbamates in sepsis treatment and apoptosis Sepsis is a severe systemic inflammation caused by dysregulated host response to pathologic infection ( Singer et al. , 2016 ), a report estimated its global incidence at 19 million people each year ( Fleischmann et al. , 2016 ). Free-oxygen radicals, lipid and protein oxidation have been implicated in sepsis pathogenesis ( Goodee & Webster, 1993 ; Prauchner, 2017 ). Lipopolysaccharides activate nuclear factor kappa B (NF-kB), activation of NF-kB results in the expression of pro-inflammatory mediators and increased biosynthesis in sepsis, which has been linked to multiple organ injury ( Ang et al. , 2011 ). Pyrrolidine dithiocarbamate has been reported to be an effective medication for sepsis treatment ( Gezmis et al. , 2019 ; Liu et al. , 1999 ). Due to their pleiotropic effects on cells, dithiocarbamates may both prevent and trigger apoptosis ( Orrenius et al ., 1996 ). They prevent apoptosis induced by a range of stimuli in short-term incubations. This has been interpreted to mean that ROS plays a function in apoptosis ( Wolfe et al ., 1994 ). Others, on the other hand, believe that dithiocarbamate prevention of apoptosis is due to oxidation of key thiols rather than broad scavenging of oxygen radicals ( Nobel et al ., 1997a ). Thus, disulfiram inhibits caspase-3, caspase-1 (whose sensitivity to disulfiram varies in vitro), and most likely additional members of the caspase family ( Nobel et al. , 1997a ). Dithiocarbamate induce apoptosis via intracellular uptake of copper by triggering the formation of ROS and proteasome inhibition ( Hogarth & Onwudiwe, 2021 ; Nobel et al. , 1995 ). The precise molecular processes underlying their anticancer effect are unknown, although mechanistic investigations have revealed that they can operate as proteasome inhibitors ( Milacic et al. , 2006 ), DNA intercalators ( Ronconi et al. , 2006 ), nuclear factor kappa B (NF-kB) inhibitors, and inactivators of various metal-containing enzymes ( Nobel et al ., 1997b ). In the presence of copper ions, disulfiram acts as an anticancer agent. With copper (Cu), it does not form a stable complex, but reacts rapidly. They are most likely transformed to thiuram disulfides, which are powerful glutathione oxidants, using a copper-catalysed process ( Burkitt et al ., 1998 ). Park et al. (2003) has postulated a mechanism that involves the initial reduction of Cu(II) to Cu(I) and the creation of bitt-4 2 + , the oxidized form of disulfiram, at the same time. The bitt-4 2 + molecule is unstable and decomposes catastrophically, resulting in the generation of 30 electrons per molecule and oxidative stress in cells ( Cen et al. , 2004 ). The significant cell death observed when exposed to disulfiram-copper combinations is most likely due to this ( Chen et al. , 2006 ). Disulfiram and Cu(II) also induce cellular apoptosis in prostate and human breast cancer cells ( Daniel et al. , 2005 ; Daniel et al. , 2007 ), suggesting that they could be used to treat resistant neuroblastoma in children ( Hogarth & Onwudiwe, 2021 ). Based on IC50 values, Zhang et al. (2008) found that this combination suppressed the growth of BE (2)C cells (a human neuroblastoma cell line) and was more potent than cisplatin. These DTC salts reduce cancer cell migration and invasion by decreasing cell proliferation and inducing apoptosis and autophagy. Dithiocarbamates in the fight against microbial pathogens Antimicrobial resistance and the subsequent lack of effective antimicrobials to combat infectious diseases has remained a global health challenge. Understanding the mechanisms of resistance, which enables new diagnostic and therapeutic approaches, antimicrobial resistance drivers in the environment, will help in combating this threat. Pathogens have evolved defensive mechanisms, such as preventing drug entry or export, altering the drug target or generating enzymes that degrade or modify the antimicrobial. As a result, antimicrobial resistance could be thought of as a Darwinian competition from antimicrobial compounds originating from natural microorganisms ( Holmes et al. , 2016 ). This challenge has resulted in fewer treatment options for patients and an increase in morbidity and mortality. As a result, we now have more serious infections that require comprehensive treatment, as well as lengthier illness causes that frequently necessitate protracted hospitalization. The costs of treating these illnesses have skyrocketed because of this. As a result, despite multiple discoveries and antimicrobial medicines already accessible for therapeutic use, continued hunt for novel drugs to combat rapidly evolving pathogens remains critical. According to the World Health Organization, antimicrobial-resistant illnesses are expected to result in the death of 10 million people by 2050. This is due in part to an increase in microbial drug resistance, as well as a slower rate of discovery of new antimicrobials ( Kaul et al. , 2021 ). Thus, there is an obvious need to discover new and effective antibiotics. A practical strategy is to focus on metallodrugs, which provide novel drug discovery prospects due to their increased potency and different modes of action ( Yeo et al. , 2021 ). DTCs have been studied as antibacterial possibilities, with activity against viruses, bacteria, fungi, and parasites, leading to clinical trials in some cases. With the recognized therapeutic usage and promise of DTC derivatives and a growing understanding of the role of metal-based medications, it seems only logical that DTC derivatives be investigated as possible antimicrobial agents. Interference with cell wall (by affecting cell permeability), metabolic interference with cellular enzymes, cellular damage owing to protein denaturing, and disruption of normal cell processes as a result of hydrogen bonding with active cellular constituents through the azomethine group ( Adeyemi & Onwudiwe, 2018 ). The permeability of these compounds through the cell membrane/wall of either Gram-positive or Gram-negative organisms was considered to guide these activities. Gram-negative bacteria pose a greater challenge because of the complex outer-lipid membrane, which is made of lipopolysaccharide. This outer membrane contributes to their antigenic specificity and makes them less penetrable than Gram-positive bacteria with simpler cell membrane ( Jabbar et al. , 2012 ). Several metal–dithiocarbamate complexes have shown moderate-to-high antibacterial activity against Gram-negative and Gram-positive bacterial pathogens on the World Health Organization's global priority list of antibiotic-resistant species. Disulfiram (DSF), a DTC derivative, inhibits Gram-positive bacterial growth in recent research, especially methicillin-resistant Staphylococcus aureus (MRSA) ( Frazier et al. , 2019 ; Sheppard et al. , 2018 ). Diethyldithiocarbamate (DDC), the bestknown DTC derivative, on the other hand, did not show any substantial inhibition of Gram-positive bacterial growth when used alone ( Frazier et al. , 2019 ). Periodontitis-causing organisms such as Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis were inhibited by PDTC, which had a medium action against S. aureus and low sensitivity to Escherichia coli ( Kang et al. , 2008 ). DTC derivatives (PDTC and DDC) have been reported to be highly effective against both growing and non-growing Mycobacterium tuberculosis persisters. These derivatives improved the efficacy of existing tuberculosis drugs ( Byrne et al. , 2007 ). Dalecki et al. (2015) on the other hand, reported that the bactericidal activities of DSF and DDC in M. tuberculosis are solely dependent on Cu + . This indicates a synergistic antibacterial activity of DSF and Cu + . This allows the complex to penetrate M. tuberculosis’s cellular defenses and its drug resistance machinery. As a result, M. tuberculosis is vulnerable to chemical attacks, and copper-interacting compounds are identified as a unique family of bacterial inhibitors. Liegner (2019) presented a case of three patients, who were treated with DSF for Lyme disease and relapsing babesiosis caused by Borrelia burgdorferi. Patients who previously required intense open-ended antibiotic therapy for Lyme disease were able to quit treatment after completing a finite course of treatment alone with DSF and were clinically healthy for periods of observation ranging from 6–23 months ( Liegner, 2019 ). The metal chelation properties of DTC complexes depend on the polarity of the metal. Due to partial positive charge sharing with donor groups and the potential for n-electron delocalization over the entire chelate ring, the polarity of the metal is greatly reduced during complexation ( Adeyemi & Onwudiwe, 2020 ; Manoussakis et al. , 1987 ). In this process, the complexes' permeability triumphs over the bacteria's lipophilic membrane, through chelation with DTC ligands, this mechanism of action was thought to block biological activities within the organism by suppressing physiologically important metals like Zn and Cu ( Manoussakis et al. , 1987 ; Vuksanović et al. , 2013 ). Another mechanism is thought to be exploited by DTCs is the formation of a hydrogen bond with the active centers of the bacterium cell constituents via the -N-C(S)SH group, which disrupts normal cell processes ( Manoussakis et al. , 1987 ). A well-known DTC derivative, potassium-3-dithiocarboxy-3-aza-5-aminopentanoate, has been postulated to react with metalloenzymes in bacteria, killing them ( Vuksanovi et al. , 2013 ). In a study by Khan et al. (2007) , the antifungal activities of DSF against Aspergillus , Candida and yeast isolates that cause life-threatening infections in immunocompromised patients were reported. Similarly, a series of DTCs were investigated against β-class carbonic anhydrase from Malassezia globosa , a fungal pathogen causing dandruff ( Vullo et al. , 2017 ). Compared to the typical sulfonamide medication acetazolamide, several DTCs were found to be more effective in suppressing M. globosa. These studies show the antifungal properties of DTCs and its derivatives in combating fungal infections. The antiviral properties of DTC and its derivatives have also been reported in the literature. Several studies and DTC drugs are in preclinical and clinical stages against coronaviruses and human immunodeficiency virus ( Kaul et al. , 2021 ). However, certain DTCs have been reported to be effective against other viruses. The antiviral activities of PDTC against influenza A ( Wiesener et al. , 2011 ), enterovirus 71 ( Lin et al. , 2015 ), herpes simplex 1 and 2 ( Qiu et al. , 2013 ), and dengue virus 2 ( Duran et al. , 2017 ) have been reported. The blockage of influenza virus-induced apoptosis is responsible for PDTC's antiviral action against influenza virus ( Uchide et al. , 2002 ). In primary cultured chorion cells generated from human fetal membranes, influenza virus increased ROS generation and apoptotic fragmentation of DNA as genetic material. The anti-influenza properties of PDTC were demonstrated by inhibition of induction of DNA fragmentation, ROS overproduction and the release of influenza particles from infected cells. Furthermore, PDTC suppressed the synthesis of complementary (cRNA and mRNA) RNAs, viral (vRNA), and influenza virus hemagglutinin up to 6 hours after infection, as well as delaying and deceasing hemagglutinin protein synthesis. PDTC did not affect apoptosis or influenza virus formation, but did inhibit ROS overproduction, suggesting that PDTC inhibited apoptosis by decreasing viral macromolecule synthesis rather than through its antioxidant impact ( Uchide et al. , 2002 ). The mechanism of PDTC on influenza virus gene replication and transcription is by chelating divalent metal ions and rapid recruitment of copper and zinc ions into cells from the extracellular medium ( Kim et al. , 1999 ). The activity of viral RNA-dependent RNA polymerase is inhibited by zinc or copper ions. Bathocuproine–copper or bathocuproine–zinc complexes have a higher inhibitory impact than bathocuproine alone ( Oxford & Perrin, 1974 ). Thujaplicin–copper complex, a metal chelator, prevents influenza virus multiplication ( Miyamoto et al ., 1998 ). As a result, it's possible that PDTC suppresses viral gene replication and transcription by increasing intracellular copper and zinc ions, or intracellular PDTC–copper and PDTC–zinc complexes, by inhibiting RNA-dependent RNA polymerase activity. If PDTC worked just as a replicative enzyme inhibitor, the viral RNA production that PDTC halted would not resume in its presence; also, earlier exposure of cells to PDTC would not amplify its action ( Takizawa et al ., 1993 ). Limitations of dithiocarbamates as therapeutic agents Dithiocarbamate and its metal complexes have been shown in numerous studies to be effective biological agents, particularly at the cellular level. However, most of these complexes are not clinically resolved. A few of the metallo-complexes have been linked to negative consequences on biological systems. These are frequently related to either the metal's toxicity or the instability of the ligand moiety ( Adeyemi & Onwudiwe, 2018 ). Metal complexation, on the other hand, is hypothesized to have a modulating effect on the metal ion's toxicity while also allowing the ligand to become more stable, thus, reducing its availability for additional side reactions. Adokoh (2020) reported that these complexes have low stability in biological systems under physiological conditions as therapeutic agents. This property continues to be a major stumbling block in the development of this type of drug. Another challenge associated with the use of DTC complexes, particularly gold complexes, is the likelihood of oxidation state shift ( Adokoh, 2020 ). Because most gold (III) compounds are largely unstable under physiological conditions and are frequently transformed into more thermodynamically stable gold (I) complexes, part of this compound's utility has been limited. Despite numerous publications suggesting that these gold (I) complexes have a more promising potential than most currently used anticancer medicines, the instability of gold (III) complex oxidation impedes the development of innovative therapeutic agents ( Adokoh, 2020 ). Conclusions There has been limited information about the protective and therapeutic properties of dithiocarbamate compounds and the mechanisms of action is yet unknown. Recent research, on the other hand, has revealed information about DTC interactions with enzymes, intracellular metal concentrations, and oxidative processes, all of which are important targets in many diseases. This review gives comprehensive information about the protective effect of DTC compounds on ameliorating damage done to various organs and its use against microbial pathogens. In vitro tests on DTC and its derivatives have yielded promising results, prompting additional in vivo testing. The utilization of these complexes in drug design could have a tremendous impact on human health and provides alternative to currently available drugs that is both cheaper and more effective. Because of their biological potentials, DTC complexes could be effective in the fight against antibiotic resistance. However, understanding their precise mechanism of action and side effects requires a significant amount of effort. Regardless of the limitations, these complexes can provide a platform 12 for the development of novel therapeutic drugs, hence fresh approaches as well as detailed studies are required to overcome their drawback. Uncovering the possibilities and drawbacks of DTCs as revolutionary medical treatments is an interesting journey ahead. Data availability Underlying data There are no data associated with this article. Faculty Opinions recommended References Adeyemi JO, Onwudiwe DC: Organotin(IV) dithiocarbamate complexes: chemistry and biological activity. Molecules. 2018; 23 (10): 2571. PubMed Abstract | Publisher Full Text | Free Full Text Adeyemi JO, Onwudiwe DC: The mechanisms of action involving dithiocarbamate complexes in biological systems. Inorg Chim Acta. 2020; 511 : 119809. Publisher Full Text Adokoh CK: Therapeutic potential of dithiocarbamate supported gold compounds. RSC Adv. 2020; 10 : 2975–2988. Publisher Full Text Ang SF, Moochhala SM, MacAry PA, et al. : Hydrogen sulfide and neurogenic inflammation in polymicrobial sepsis: involvement of substance P and ERK-NF-κB signaling. PLoS One. 2011; 6 (9): e24535. PubMed Abstract | Publisher Full Text | Free Full Text Borghi SM, Fattori V, Ruiz-Miyazawa KW, et al. : Pyrrolidine dithiocarbamate inhibits mouse acute kidney injury induced by diclofenac by targeting oxidative damage, cytokines and NF-κB activity. Life Sci. 2018; 208 : 221–231. PubMed Abstract | Publisher Full Text Bruck R, Aeed H, Schey R, et al. : Pyrrolidine dithiocarbamate protects against thioacetamide-induced fulminant hepatic failure in rats. J Hepatol. 2002; 36 (3): 370–377. PubMed Abstract | Publisher Full Text Buac D, Schmitt S, Ventro G, et al. : Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells. Mini Rev Med Chem. 2012; 12 (12): 1193–1201. PubMed Abstract | Publisher Full Text | Free Full Text Burkitt MJ, Bishop HS, Milne L, et al. : Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species. Arch Biochem Biophys. 1998; 353 (1): 73–84. PubMed Abstract | Publisher Full Text Byrne ST, Gu P, Zhou J, et al. : Pyrrolidine dithiocarbamate and diethyldithiocarbamate are active against growing and nongrowing persister Mycobacterium tuberculosis . Antimicrob Agents Chemother. 2007; 51 (12): 4495–4497. PubMed Abstract | Publisher Full Text | Free Full Text Cen D, Brayton D, Shahandeh B, et al. : Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J Med Chem. 2004; 47 (27): 6914–6920. PubMed Abstract | Publisher Full Text Chen D, Cui QC, Yang H, et al. : Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res. 2006; 66 (21): 10425–10433. PubMed Abstract | Publisher Full Text Dalecki AG, Haeili M, Shah S, et al. : Disulfiram and copper ions kill Mycobacterium tuberculosis in a synergistic manner. Antimicrob Agents Chemother. 2015; 59 (8): 4835–4844. PubMed Abstract | Publisher Full Text | Free Full Text Daniel KG, Chen D, Orlu S, et al. : Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. Breast Cancer Res. 2005; 7 (6): R897–908. PubMed Abstract | Publisher Full Text | Free Full Text Daniel KG, Chen D, Yan B, et al. : Copper-binding compounds as proteasome inhibitors and apoptosis inducers in human cancer. Front Biosci. 2007; 12 : 135–44. PubMed Abstract | Publisher Full Text de Lamirande E, Gagnon C: Impact of reactive oxygen species on spermatozoa: a balancing act between beneficial and detrimental effects. Hum Reprod. 1995; 10 Suppl 1 : 15–21. PubMed Abstract | Publisher Full Text Duran A, Valero N, Mosquera J, et al. : Gefitinib and pyrrolidine dithiocarbamate decrease viral replication and cytokine production in dengue virus infected human monocyte cultures. Life Sci. 2017; 191 : 180–185. PubMed Abstract | Publisher Full Text Eren G, Cukurova Z, Hergunsel O, et al. : Protective Effect of the Nuclear Factor Kappa B Inhibitor Pyrrolidine Dithiocarbamate in Lung Injury in Rats with Streptozotocin-Induced Diabetes. Respiration. 2010; 79 (5): 402–410. PubMed Abstract | Publisher Full Text Fleischmann C, Scherag A, Adhikari NK, et al. : Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016; 193 (3): 259–272. PubMed Abstract | Publisher Full Text Frazier K, Moore J, Long T: Antibacterial activity of disulfiram and its metabolites. J Appl Microbiol. 2019; 126 (1): 79–86. PubMed Abstract | Publisher Full Text Gezmis A, Balkan B, Yektas AK: Protective Effect of Pyrrolidine Dithiocarbamate to Liver Injury in a Sepsis Model with Cecum Ligation and Perforation - An Animal Study. Ann Clin Lab Res. 2019; 7 (1): 294. Reference Source Goode HF, Webster NR: Free radicals and antioxidants in sepsis. Crit Care Med. 1993; 21 (11): 1770–1776. PubMed Abstract | Publisher Full Text Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, Ed 4. Clarendon Press, Oxford. 2006. Hellerbrand C, Jobin C, Licato LL, et al. : Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol. 1998; 275 (2): G269–G278. PubMed Abstract | Publisher Full Text Hidaka S, Funakoshi T, Shimada H, et al. : Protective effect of N-benzyl-D-glucamine dithiocarbamate against renal toxicity in rats during repeated cis-diamminedichloroplatinum administrations. Ren Fail. 1995; 17 (5): 539– 550. PubMed Abstract | Publisher Full Text Hogarth G, Onwudiwe DC: Copper Dithiocarbamates: Coordination chemistry and applications in materials science, biosciences and beyond. Inorganics. 2021; 9 (9): 70. Publisher Full Text Hogarth G: Transition metal dithiocarbamates: 1978-2003. Progress in Inorganic Chemistry. 2005; 53 : 71–561. Publisher Full Text Holmes AH, Moore LSP, Sundsfjord A, et al. : Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016; 387 (10014): 176–187. PubMed Abstract | Publisher Full Text Jabbar S, Shahzadi I, Rehman R, et al. : Synthesis, characterization, semi-empirical study, and biological activities of organotin (IV) complexes with cyclohexylcarbamodithioic acid as biological active ligand. Journal of Coordination Chemistry. 2012; 65 : 572–590. Publisher Full Text Joyce DA: Oxygen radicals in disease. Adverse Drug Reaction Bull. 1987; 127 : 476–479. Reference Source Kang MS, Choi EK, Choi DH, et al. : Antibacterial activity of pyrrolidine dithiocarbamate. FEMS Microbiol Lett. 2008; 280 (2): 250–254. PubMed Abstract | Publisher Full Text Kaul L, Süss R, Zannettino A, et al. : The revival of dithiocarbamates: from pesticides to innovative medical treatments. iScience. 2021; 24 (2): 102092. PubMed Abstract | Publisher Full Text | Free Full Text Khan S, Singhal S, Mathur T, et al. : Antifungal potential of disulfiram. Nihon Ishinkin Gakkai Zasshi. 2007; 48 (3): 109–113. PubMed Abstract | Publisher Full Text Kim CH, Kim JH, Hsu CY, et al. : Zinc is required in pyrrolidine dithiocarbamate inhibition of NF-Kappab activation. FEBS Lett. 1999; 449 (1): 28–32. PubMed Abstract | Publisher Full Text Lal N: Dithiocarbamates: a versatile class of compounds in medicinal chemistry. Chemistry and Biology Interface. 2014; 4 : 321–340. Liegner KB: Disulfiram (Tetraethylthiuram Disulfide) in the treatment of lyme disease and babesiosis: report of experience in three cases. Antibiotics (Basel). 2019; 8 (2): 72. PubMed Abstract | Publisher Full Text | Free Full Text Lin L, Qin Y, Wu H, et al. : Pyrrolidine dithiocarbamate inhibits enterovirus 71 replication by down-regulating ubiquitin-proteasome system. Virus Res. 2015; 195 : 207–216. PubMed Abstract | Publisher Full Text Liu SF, Ye X, Malik AB: Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol Pharmacol. 1999; 55 (4): 658–667. PubMed Abstract Liu J, Shigenaga MK, Yan L, et al. : Free Radicals Res. 1996; 24 : 461–472. Mankhetkorn S, Abedinzadeh Z, Houee-Levin C: Free Radicals Biol Med. 1994; 17 : 517–527. Manoussakis G, Bolos C, Ecateriniadou L, et al. : Synthesis, characterization and anti-bacterial studies of mixed-ligand complexes of dithiocarbamato–Thiocyanato and iron(III), nickel(II), copper(II) and zinc(II). Eur J Med Chem. 1987; 22 (5): 421–425. Publisher Full Text Milacic V, Chen D, Ronconi L, et al. : A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts. Cancer Res. 2006; 66 (21): 10478–10486. PubMed Abstract | Publisher Full Text Miller DM, Buettner GR, Aust SD: Transition metals as catalysts of "autoxidation" reactions. Free Radic Biol Med. 1990; 8 (1): 95–108. PubMed Abstract | Publisher Full Text Miyamoto D, Kusagaya Y, Endo N, et al. : Thujaplicin-copper chelates inhibit replication of human influenza viruses. Antiviral Res. 1998; 39 (2): 89–100. PubMed Abstract | Publisher Full Text Movassagh B, Shokri B: A facile and efficient one-pot regioselective synthesis of 2-hydroxyalkyl dithiocarbamates under catalyst-free conditions. Int J Org Chem (Irvine). 2012; 2 (3): 248–253. Publisher Full Text Muriel P: Some experimental models of liver damage. In Hepatotoxicity: from Genomics to in Vitro and in Vivo Models. Sahu S (ed.). Wiley: Chichester; 2007a; 119–137. Publisher Full Text Muriel P: Cytokines in liver diseases. In Hepatotoxicity: from Genomics to in Vitro and in Vivo Models. Sahu S (ed.). Wiley: Chichester; 2007b; 371–389. Nobel CI, Kimland M, Lind B, et al. : Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper. J Biol Chem. 1995; 270 (44): 26202–8. PubMed Abstract | Publisher Full Text Nobel CS, Kimland M, Nicholson DW, et al. : Disulfiram is a potent inhibitor of proteases of the caspase family. Chem Res Toxicol. 1997a; 10 (12): 1319–1324. PubMed Abstract | Publisher Full Text Nobel CS, Burgess DH, Zhivotovsky B, et al. : Mechanism of dithiocarbamate inhibition of apoptosis: thiol oxidation by dithiocarbamate disulfides directly inhibits processing of the caspase-3 proenzyme. Chem Res Toxicol. 1997b; 10 (6): 636–43. PubMed Abstract | Publisher Full Text Onwudiwe DC, Ekennia AC: Synthesis, characterization, thermal, antimicrobial and antioxidant studies of some transition metal dithiocarbamates. Res Chem Intermed. 2017; 43 : 1465–1485. Publisher Full Text Orrenius S, Nobel CS, van den Dobbelsteen DJ, et al. : Dithiocarbamates and the redox regulation of cell death. Biochem Soc Trans. 1996; 24 (4): 1032–1038. PubMed Abstract | Publisher Full Text Oxford JS, Perrin DD: Inhibition of the particle-associated RNA-dependent RNA polymerase activity of influenza viruses by chelating agents. J Gen Virol. 1974; 23 (1): 59–71. PubMed Abstract | Publisher Full Text Park JH, Afzaal M, Kemmler M, et al. : The deposition of thin films of CuME 2 by CVD techniques (M = In, Ga and E = S, Se). J Mater Chem. 2003; 13 (8): 1942–1949. Publisher Full Text Parsons CJ, Takashima M, Rippe RA: Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol. 2007; 22 Suppl 1 : S79–S84. PubMed Abstract | Publisher Full Text Prauchner CA: Oxidative stress in sepsis: pathophysiological implications justifying antioxidant co-therapy. Burns. 2017; 43 (3): 471–485. PubMed Abstract | Publisher Full Text Qiu M, Chen Y, Cheng L, et al. : Pyrrolidine dithiocarbamate inhibits herpes simplex virus 1 and 2 replication, and its activity may be mediated through dysregulation of the ubiquitin-proteasome system. J Virol. 2013; 87 (15): 8675–8686. PubMed Abstract | Publisher Full Text | Free Full Text Ronconi L, Marzano C, Zanello P, et al. : Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties. J Med Chem. 2006; 49 (5): 1648–1657. PubMed Abstract | Publisher Full Text Schini-Kerth V, Bara A, Mülsch A, et al. : Pyrrolidine dithiocarbamate selectively prevents the expression of the inducible nitric oxide synthase in the rat aorta. Eur J Pharmacol. 1994; 265 (1–2): 83–87. PubMed Abstract | Publisher Full Text Schreck R, Meier B, Männel DN, et al. : Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med. 1992; 175 (5): 1181–1194. PubMed Abstract | Publisher Full Text | Free Full Text Sharma RK, Agarwal A: Role of reactive oxygen species in male infertility. Urology. 1996; 48 (6): 835–850. PubMed Abstract | Publisher Full Text Sheppard JG, Frazier KR, Saralkar P, et al. : Disulfiram-based disulfides as narrow-spectrum antibacterial agents. Bioorg Med Chem Lett. 2018; 28 (8): 1298–1302. PubMed Abstract | Publisher Full Text | Free Full Text Sikka SC: Relative impact of oxidative stress on male reproductive function. Curr Med Chem. 2001; 8 (7): 851–862. PubMed Abstract | Publisher Full Text Sikka SC, Rajasekaran M, Hellstrom WJ: Role of oxidative stress and antioxidants in male infertility. J Androl. 1995; 16 (6): 464–468. PubMed Abstract Singer M, Deutschman CS, Seymour CW, et al. : The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315 (8): 801–810. PubMed Abstract | Publisher Full Text | Free Full Text Takizawa T, Matsukawa S, Higuchi Y, et al. : Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol. 1993; 74 (Pt 11): 2347–55. PubMed Abstract | Publisher Full Text Uchide N, Ohyama K, Bessho T, et al. : Effect of antioxidants on apoptosis induced by influenza virus infection: inhibition of viral gene replication and transcription with pyrrolidine dithiocarbamate. Antiviral Res. 2002; 56 (3): 207–17. PubMed Abstract | Publisher Full Text Valko M, Morris H, Cronin MT: Metals, toxicity and oxidative stress. Curr Med Chem. 2005; 12 (10): 1161–1208. PubMed Abstract | Publisher Full Text Vuksanović V, Leka Z, Terzić N: Antibacterial effect of synthesized dithiocarbamate KDAAP. Fresenius Environ Bull. 2013; 22 : 3803–3807. Vullo D, Del Prete S, Nocentini A, et al. : Dithiocarbamates effectively inhibit the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa . Bioorg Med Chem. 2017; 25 (3): 1260–1265. PubMed Abstract | Publisher Full Text Wiesener N, Zimmer C, Jarasch-Althof N, et al. : Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate. Med Microbiol Immunol. 2011; 200 (2): 115–126. PubMed Abstract | Publisher Full Text Wolfe JT, Ross D, Cohen GM: A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Lett. 1994; 352 (1): 58–62. PubMed Abstract | Publisher Full Text Yeo CI, Tiekink ERT, Chew J: Insights into the antimicrobial potential of dithiocarbamate anions and metal-based species. Inorganics. 2021; 9 (6): 48. Publisher Full Text Zanocco AL, Pavez R, Videla LA, et al. : Antioxidant capacity of diethyldithiocarbamate in a metal independent lipid peroxidative process. Free Radic Biol Med. 1989; 7 (2): 151–156. PubMed Abstract | Publisher Full Text Zhang H, Wu JS, Peng F: Potent anticancer activity of pyrrolidine dithiocarbamate-copper complex against cisplatin-resistant neuroblastoma cells. Anticancer Drugs. 2008; 19 (2): 125–132. PubMed Abstract | Publisher Full Text Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 28 Feb 2022 ADD YOUR COMMENT Comment Author details Author details 1 Biochemistry, North-West University, Mmabatho, North West, 2735, South Africa 2 Microbiology and Biochemistry, University of the Free State, Bloemfontein, Free State, 9301, South Africa 3 Food Security and Safety, North-West University, Mmabatho, North West, 2735, South Africa Toluwani Tella Roles: Conceptualization, Data Curation, Investigation, Writing – Original Draft Preparation, Writing – Review & Editing Carolina H. Pohl Roles: Project Administration, Resources, Writing – Review & Editing Ayansina Ayangbenro Roles: Data Curation, Investigation, Resources, Writing – Original Draft Preparation, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information The author(s) declared that no grants were involved in supporting this work. Article Versions (1) version 1 Published: 28 Feb 2022, 11:243 https://doi.org/10.12688/f1000research.109553.1 Copyright © 2022 Tella T et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article Tella T, Pohl CH and Ayangbenro A. A review of the therapeutic properties of dithiocarbamates [version 1; peer review: 2 approved with reservations] . F1000Research 2022, 11 :243 ( https://doi.org/10.12688/f1000research.109553.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Version 1 VERSION 1 PUBLISHED 28 Feb 2022 Views 0 Cite How to cite this report: Chew J. Reviewer Report For: A review of the therapeutic properties of dithiocarbamates [version 1; peer review: 2 approved with reservations] . F1000Research 2022, 11 :243 ( https://doi.org/10.5256/f1000research.121066.r180034 ) The direct URL for this report is: https://f1000research.com/articles/11-243/v1#referee-response-180034 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 05 Jul 2023 Jactty Chew , Sunway University, Selangor Darul Ehsan, Malaysia Approved with Reservations VIEWS 0 https://doi.org/10.5256/f1000research.121066.r180034 The manuscript provides an overview of the protective and therapeutic effects of dithiocarbamates (DTCs). However, it seems that the manuscript currently has a selective focus on the therapeutic effects of DTCs in liver, lungs, and kidney, but it lacks comprehensive ... Continue reading READ ALL The manuscript provides an overview of the protective and therapeutic effects of dithiocarbamates (DTCs). However, it seems that the manuscript currently has a selective focus on the therapeutic effects of DTCs in liver, lungs, and kidney, but it lacks comprehensive coverage of the therapeutic effects of DTCs on sepsis. Though the antimicrobial activity of DTCs was reviewed, many of references were not included. Hence, the manuscript requires editing to improve the quality of the review. To address these concerns and improve the manuscript, here are some suggestions: To include additional studies on the therapeutic effects of DTCs on sepsis and expand the discussion on the therapeutic effects of DTCs in the context of sepsis treatment. Since the manuscript acknowledges that other groups have reviewed the antimicrobial activity of DTCs, it would be beneficial to include a summary of the key findings from those reviews. additionally, authors may consider reviewing new articles published since the previous reviews to include the most recent findings on the antimicrobial effects of DTCs. Include relevant references to support the discussion. To justify the selection of articles. If the manuscript only includes selected articles on the therapeutic effects of DTCs in liver, lungs, and kidney, provide a clear rationale for the inclusion of those specific studies. Authors may explain why those studies were chosen and how they contribute to the overall understanding of DTCs' protective effects in those organs. This will help readers understand the reasoning behind the selection and any potential limitations associated with it. By addressing these points, the manuscript will provide a more comprehensive and balanced review of the therapeutic effects of DTCs, including their effects on sepsis and antimicrobial activity. Is the topic of the review discussed comprehensively in the context of the current literature? Partly Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Partly Are the conclusions drawn appropriate in the context of the current research literature? Partly Competing Interests: No competing interests were disclosed. Reviewer Expertise: Antimicrobial development I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Chew J. Reviewer Report For: A review of the therapeutic properties of dithiocarbamates [version 1; peer review: 2 approved with reservations] . F1000Research 2022, 11 :243 ( https://doi.org/10.5256/f1000research.121066.r180034 ) The direct URL for this report is: https://f1000research.com/articles/11-243/v1#referee-response-180034 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Adokoh CK. Reviewer Report For: A review of the therapeutic properties of dithiocarbamates [version 1; peer review: 2 approved with reservations] . F1000Research 2022, 11 :243 ( https://doi.org/10.5256/f1000research.121066.r125694 ) The direct URL for this report is: https://f1000research.com/articles/11-243/v1#referee-response-125694 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 23 May 2022 Christian K. Adokoh , Department of Forensic Sciences, University of Cape Coast, Cape Coast, Ghana Approved with Reservations VIEWS 0 https://doi.org/10.5256/f1000research.121066.r125694 The work of Ayangbenro et al. is an interesting and well-written summarized review that describes the therapeutic properties of dithiocarbamates. Mainly it highlights the protective and therapeutic properties of dithiocarbamate compounds in biological systems. It is a topic of great interest ... Continue reading READ ALL The work of Ayangbenro et al. is an interesting and well-written summarized review that describes the therapeutic properties of dithiocarbamates. Mainly it highlights the protective and therapeutic properties of dithiocarbamate compounds in biological systems. It is a topic of great interest and I presume that it will be highly referenced by many authors working in drug discovery, especially those devoted to medicinal chemistry. The scheme followed describing the antioxidant properties of these compounds, treatment and prevention of organ damage, sepsis treatment and apoptosis, its limitations and conclusion is comprehensive and well-structured with up-to-date references containing the most essential data. In summary, a paper that I recommend for indexing. But my approval comes with some reservation due to minor points that should be considered prior to indexing and, under my point of view, would favour the understanding of the review. They refer to small editing changes I have already pointed out in the attached annotated manuscript. Is the topic of the review discussed comprehensively in the context of the current literature? No Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Partly Competing Interests: No competing interests were disclosed. Reviewer Expertise: Medicinal chemistry I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Adokoh CK. Reviewer Report For: A review of the therapeutic properties of dithiocarbamates [version 1; peer review: 2 approved with reservations] . F1000Research 2022, 11 :243 ( https://doi.org/10.5256/f1000research.121066.r125694 ) The direct URL for this report is: https://f1000research.com/articles/11-243/v1#referee-response-125694 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 28 Feb 2022 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Reviewer Reports Invited Reviewers 1 2 Version 1 28 Feb 22 read read Christian K. Adokoh , University of Cape Coast, Cape Coast, Ghana Jactty Chew , Sunway University, Selangor Darul Ehsan, Malaysia Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2023 Chew J. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 05 Jul 2023 | for Version 1 Jactty Chew , Sunway University, Selangor Darul Ehsan, Malaysia 0 Views copyright © 2023 Chew J. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved With Reservations info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The manuscript provides an overview of the protective and therapeutic effects of dithiocarbamates (DTCs). However, it seems that the manuscript currently has a selective focus on the therapeutic effects of DTCs in liver, lungs, and kidney, but it lacks comprehensive coverage of the therapeutic effects of DTCs on sepsis. Though the antimicrobial activity of DTCs was reviewed, many of references were not included. Hence, the manuscript requires editing to improve the quality of the review. To address these concerns and improve the manuscript, here are some suggestions: To include additional studies on the therapeutic effects of DTCs on sepsis and expand the discussion on the therapeutic effects of DTCs in the context of sepsis treatment. Since the manuscript acknowledges that other groups have reviewed the antimicrobial activity of DTCs, it would be beneficial to include a summary of the key findings from those reviews. additionally, authors may consider reviewing new articles published since the previous reviews to include the most recent findings on the antimicrobial effects of DTCs. Include relevant references to support the discussion. To justify the selection of articles. If the manuscript only includes selected articles on the therapeutic effects of DTCs in liver, lungs, and kidney, provide a clear rationale for the inclusion of those specific studies. Authors may explain why those studies were chosen and how they contribute to the overall understanding of DTCs' protective effects in those organs. This will help readers understand the reasoning behind the selection and any potential limitations associated with it. By addressing these points, the manuscript will provide a more comprehensive and balanced review of the therapeutic effects of DTCs, including their effects on sepsis and antimicrobial activity. Is the topic of the review discussed comprehensively in the context of the current literature? Partly Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Partly Are the conclusions drawn appropriate in the context of the current research literature? Partly Competing Interests No competing interests were disclosed. Reviewer Expertise Antimicrobial development I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. reply Respond to this report Responses (0) Chew J. Peer Review Report For: A review of the therapeutic properties of dithiocarbamates [version 1; peer review: 2 approved with reservations] . F1000Research 2022, 11 :243 ( https://doi.org/10.5256/f1000research.121066.r180034) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/11-243/v1#referee-response-180034 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2022 Adokoh C. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 23 May 2022 | for Version 1 Christian K. Adokoh , Department of Forensic Sciences, University of Cape Coast, Cape Coast, Ghana 0 Views copyright © 2022 Adokoh C. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved With Reservations info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The work of Ayangbenro et al. is an interesting and well-written summarized review that describes the therapeutic properties of dithiocarbamates. Mainly it highlights the protective and therapeutic properties of dithiocarbamate compounds in biological systems. It is a topic of great interest and I presume that it will be highly referenced by many authors working in drug discovery, especially those devoted to medicinal chemistry. The scheme followed describing the antioxidant properties of these compounds, treatment and prevention of organ damage, sepsis treatment and apoptosis, its limitations and conclusion is comprehensive and well-structured with up-to-date references containing the most essential data. In summary, a paper that I recommend for indexing. But my approval comes with some reservation due to minor points that should be considered prior to indexing and, under my point of view, would favour the understanding of the review. They refer to small editing changes I have already pointed out in the attached annotated manuscript. Is the topic of the review discussed comprehensively in the context of the current literature? No Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Partly Competing Interests No competing interests were disclosed. Reviewer Expertise Medicinal chemistry I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. reply Respond to this report Responses (0) Adokoh CK. Peer Review Report For: A review of the therapeutic properties of dithiocarbamates [version 1; peer review: 2 approved with reservations] . F1000Research 2022, 11 :243 ( https://doi.org/10.5256/f1000research.121066.r125694) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/11-243/v1#referee-response-125694 Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "A review of the therapeutic properties of...".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/11-243/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/11-243/v1&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/11-243/v1" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('Tella T et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://f1000research.com/articles/11-243/v1/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://f1000research.com/articles/11-243", templates : { twitter : "A review of the therapeutic properties of dithiocarbamates. Tella T et al., published by " + "@F1000Research" + ", https://f1000research.com/articles/11-243/v1" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/109553/121066") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("articles", "article", "121066"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "125697": 0, "180034": 8, "180035": 0, "125696": 0, "180032": 0, "180033": 0, "180036": 0, "180037": 0, "138422": 0, "138421": 0, "124249": 0, "180026": 0, "180030": 0, "125693": 0, "180031": 0, "125692": 0, "180028": 0, "125695": 0, "125694": 17, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "83a2fa77-1b40-4b88-af6d-2a1e0d1e9fd6"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: "f1000research", displayName: "F1000Research", hostName: "f1000research.com", id: "1", editorialEmail: "[email protected]", infoEmail: "[email protected]", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(".cookie-warning").is(":visible")) { $(".sticky").css("margin-bottom", "35px"); $(".devices").addClass("devices-and-cookie-warning"); } $(".cookie-warning .close-button").click(function (e) { $(".devices").removeClass("devices-and-cookie-warning"); $(".sticky").css("margin-bottom", "0"); }); $("#tweeter-feed .tweet-message").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(".partner").on("mouseenter mouseleave", function() { $(this).find(".gray-scale, .colour").toggleClass("is-hidden"); }); }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); });